Loading organizations...
Loading organizations...
Immuno-oncology biotech developing antibody-drug conjugate therapies.
Fortis Therapeutics has raised $58.0M across 2 funding rounds.
Fortis Therapeutics has raised $58.0M in total across 2 funding rounds.
Fortis Therapeutics has raised $58.0M in total across 2 funding rounds.
Fortis Therapeutics's investors include Avalon Ventures, Bregua Corporation, Fulcrum 2020, Lilly Asia Ventures, Myeloma Investment Fund, Osage University Partners, Vivo Capital, Jay Lichter.
Fortis Therapeutics has raised $58.0M across 2 funding rounds. Most recently, it raised $40.0M Series A in March 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 29, 2021 | $40.0M Series A | Avalon Ventures, Bregua Corporation, Fulcrum 2020, Lilly Asia Ventures, Myeloma Investment Fund, Osage University Partners, Vivo Capital | |
| Sep 27, 2016 | $18.0M Series A | Jay Lichter | Bregua Corporation, Lilly Asia Ventures, Osage University Partners, Vivo Capital |